NKGen Biotech, today announced that compassionate use cases of SNK01 + an immune checkpoint inhibitor in patients with advanced sarcoma have been accepted for poster presentation at the European Society for Medical Oncology (ESMO) Annual Congress being held in Paris, France, September 9 – 13, 2022.
September 6, 2022
· 2 min read